KFDA Views Hanmi's Anti-obesity Drug Slimer as Generic Version

Published: 2005-03-18 06:59:00

Updated: 2005-03-18 06:59:00

The Korea Food and Drug Administration (KFDA) recently expressed of its position to recognize Hanmi Pharmaceutical's anti-obesity drug Slimer as an equivalent generic version to the original drug Reductil by Abbott Korea, thus treating both as the same products.

According to the industry sourc...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK